In line with the current findings, individuals with MetS exhibit low-grade inflammation evidenced by increased secretion of pro-inflammatory factors from adipose tissue, including MCP-1, macrophage migration inhibitory factor, chemokine ligand 5, and macrophage colony-stimulating factor [47]. The gene discussed is CCL2; the disease is metabolic syndrome.